Skip to main content
OpenTrials
Completed

NCT Number: NCT02834065

Cognitive Effects of Body Temperature During Hypothermic Circulatory Arrest

In this study the investigator will randomize 273 subjects to deep (<20°C), low (20.1°C-24°C), or moderate (24.1°C-28°C) hypothermia during aortic arch surgery with circulatory arrest. The primary purpose of this study is to determine the effect of deep vs low vs moderate hypothermia on neurocognitive function, brain functional connectivity, and leukocyte SUMOylation patterns after surgical circulatory arrest in participants.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

Loading trial locations.

About this study

Purpose of the Study: Determine the effect of deep vs low vs moderate hypothermia on neurocognitive function, brain functional connectivity, and leukocyte SUMOylation patterns after surgical circulatory arrest.

Hypothesis: Deep hypothermia is superior to moderate hypothermia in reducing postoperative cognitive decline and preserving brain functional connectivity and that low hypothermia is non-inferior to deep hypothermia.

Design and Procedures: 273 informed and consenting patients who are scheduled for elective proximal aortic reconstructive surgery (ascending aorta + aortic valve or root) with concomitant proximal hemi- or total arch replacement via median sternotomy will be randomized to deep (<20°C), low (20.1°C-24°C), or moderate (24.1°C-28°C) hypothermia during circulatory arrest. Cognitive testing using a standard battery will occur preoperatively (baseline), at 4 weeks, and at 1 year after surgery. Neuroimaging procedures before surgery, and at 4 weeks and 1 year after surgery will consist of high-resolution anatomic, resting-state fMRI (rs-fMRI) and magnetic resonance spectroscopy (MRS) sequences. To characterize leukocyte activation, whole blood will be drawn at 5 time points: at baseline (prior to surgery), before circulatory arrest, 10 minutes after reperfusion, 10 minutes after CPB, and 4 hours after CPB.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who are scheduled for elective proximal aortic reconstructive surgery (ascending aorta + aortic valve or root) with concomitant proximal hemi- or total arch replacement via median sternotomy

Exclusion criteria

  • < 18 years of age
  • History of symptomatic cerebrovascular disease, eg, prior stroke with residual deficit
  • Alcoholism (> 2 drinks/day)
  • Psychiatric illness (any clinical diagnoses requiring therapy)
  • Drug abuse (any illicit drug use in the past 3 months)
  • Hepatic insufficiency (liver function tests > 1.5 times the upper limit of normal)
  • Severe pulmonary insufficiency (requiring home oxygen therapy)
  • Renal failure (serum creatinine > 2.0 mg/dL)
  • Claustrophobic fear
  • Unable to read and thus unable to complete the cognitive testing
  • Pregnant women
  • Patients who score < 24 on a baseline Mini Mental State Examination (MMSE) or ≥ 27 on the baseline Center for Epidemiological Studies Depression (CES-D) scale
  • Patients who have pre-existing unsafe implants for 3 Tesla magnetic resonance imaging (MRI).
  • Patients who have received chemotherapy in the last 12 months.
  • Patients with COVID-19 diagnosis within the past 12 months

Treatment and study plan

Cardiopulmonary bypass machine

Device

Routinely used cardiopulmonary bypass machine (standard of care) will be used to initiate circulatory arrest

Primary outcomes

  1. Change in short-term cognition as measured by continuous cognitive score

    Time frame: From baseline to 4 weeks post-operatively

    To characterize cognitive function over time while minimizing potential redundancy in the cognitive measures, a factor analysis will be performed on the cognitive test scores from baseline. A continuous change score will be calculated by subtracting the baseline cognitive index (the mean of the domain scores from factor analysis) from the follow-up cognitive index at 4 weeks.

Secondary outcomes

  1. Change in SUMO 2/3 levels

    Time frame: Pre-incision, before circulatory arrest, 10 minutes after reperfusion, 10 minutes after cardiopulmonary bypass, 4 hrs after cardiopulmonary bypass

  2. Change in long-term cognition as measured by continuous cognitive score

    Time frame: From baseline to 1 year post-operatively

    To characterize cognitive function over time while minimizing potential redundancy in the cognitive measures, a factor analysis will be performed on the cognitive test scores from baseline. A continuous change score will be calculated by subtracting the baseline cognitive index (the mean of the domain scores from factor analysis) from the follow-up cognitive index at 1 year.

  3. Incidence of delirium

    Time frame: Up to post-operative day 3

    Confusion Assessment Method (CAM)

  4. Change in neurological function as measured by NIHSS

    Time frame: Assessed at baseline, post-op day 4, 4 weeks

  5. Change in neuronal metabolism

    Time frame: From baseline to 4 weeks

    Magnetic resonance spectra (metabolic peaks) of myoinositol, creatine, choline and N-acetyl aspartate

  6. Change in resting-state functional connectivity

    Time frame: From baseline to 4 weeks post-operatively

    For the rs-fMRI data, the analyses of primary interest will be the spontaneous, low-frequency fluctuations in the blood oxygen level dependent (BOLD) data of the Default Mode, Salience, and Executive Control Networks.

  7. Change in Duke Activity Status Index score

    Time frame: From baseline to 4 weeks postoperatively

  8. Change in depression score

    Time frame: From baseline to 4 weeks postoperatively

    Measured by the Center for Epidemiological Studies Depression Scale (CES-D).

  9. Change in anxiety score

    Time frame: From baseline to 4 weeks postoperatively

    Measured by State Trait Anxiety Inventory (STA-I).

  10. Change in SF-36 score

    Time frame: From baseline to 1 year postoperatively

  11. Change in employment status

    Time frame: From baseline to 1 year postoperatively

Sponsors and collaborators

Lead sponsor

Duke University

Other

Collaborators

  • Baylor Scott and White Health
  • Emory Healthcare
  • National Heart, Lung, and Blood Institute (NHLBI)
  • National Institutes of Health (NIH)
  • University of Pennsylvania

Registry information

Important dates

Study start
2016
Primary completion
2022
Study completion
2023
First posted
Jul 15, 2016
Registry last updated
Feb 24, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.